Related Experiment Videos
Xenovulene A, a novel GABA-benzodiazepine receptor binding compound produced by Acremonium strictum
A M Ainsworth1, M I Chicarelli-Robinson, B R Copp
1Xenova Ltd, Slough Berkshire, U.K.
The Journal of Antibiotics
|July 1, 1995
Abstract:
Xenovulene A, a novel inhibitor of benzodiazepine binding to the GABA-benzodiazepine receptor is produced by submerged fermentation of Acremonium strictum. It was isolated from the mycelium by solvent extraction and purified by chromatography on Sephadex LH-20 and octadecyl silica. The structure of xenovulene A was determined to be a novel oxygenated sesquiterpene containing a humulene moiety by interpretation of various spectroscopic data, especially from 2D NMR experiments. Xenovulene A inhibited binding of the benzodiazepine, flunitrazepam, with an IC50 of 40 nM in an in vitro assay using bovine synaptosome membrane preparations.